COMMUNIQUÉS West-GlobeNewswire

International Stem Cell Corporation Granted Key US Patent Protecting Anti-Aging Business
15/01/2019
CARLSBAD, Calif., Jan. 15, 2019 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQB: ISCO) ( www.internationalstemcell.com ) ("ISCO" or "the Company"), a California-based, clinical stage biotechnology company [...]
Yield10 Bioscience Reports Encouraging Results from 2018 Field Tests of C3003 and Announces Advancement of C3003 into Commercial Development for Canola
15/01/2019
WOBURN, Mass., Jan. 15, 2019 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN), a Company developing new technologies to create step-change improvements in crop yield that enhance global food security, today [...]
Medovex Corporation Announces New Board Appointments
15/01/2019
Finance Industry Veterans Join Board of Directors Following Successful Closing of Regenerative Medicine Solutions Acquisition ALPHARETTA, Ga., Jan. 15, 2019 (GLOBE NEWSWIRE) -- Medovex Corporation (OTCQB: MDVX) (“ [...]
Menlo Therapeutics’ Serlopitant Granted Breakthrough Therapy Designation by FDA for the Treatment of Pruritus Associated with Prurigo Nodularis
15/01/2019
REDWOOD CITY, Calif., Jan. 15, 2019 (GLOBE NEWSWIRE) -- Menlo Therapeutics Inc. (NASDAQ: MNLO), a late-stage biopharmaceutical company focused on the development of serlopitant for the treatment of pruritus (itch), [...]
VistaGen Therapeutics Appoints Pharmaceutical Industry Veteran, Ann Cunningham, to its Board of Directors
15/01/2019
SOUTH SAN FRANCISCO, Calif., Jan. 15, 2019 (GLOBE NEWSWIRE) -- VistaGen Therapeutics (NASDAQ: VTGN), a clinical-stage biopharmaceutical company developing new generation medicines for central nervous system (CNS) [...]
Large-scale paediatric SLIT-tablet trial meets primary endpoint, confirming potential in children
15/01/2019
ALK ( ALKB:DC / OMX: ALK B / AKABY / AKBLF ): Phase III efficacy and safety trial of ragweed SLIT-tablet involved over 1,000 children aged 5 to 17 in North America and Europe Primary endpoint was met, with a major [...]
Biomerica Announces Second Quarter Financial Results
15/01/2019
IRVINE, Calif., Jan. 15, 2019 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq:BMRA) today reported net sales of $1,500,791 for the three months ended November 30, 2018, compared to $1,613,636 for the same period in the [...]
Premier Orthopaedics selects Allscripts to provide connected health IT platform
15/01/2019
Orthopaedic group signs strategic agreement to deploy Allscripts Professional EHR™, Allscripts® Practice Management, FollowMyHealth® and full Payerpath® suite of solutions CHICAGO, Jan. 15, 2019 (GLOBE NEWSWIRE) -- [...]
Biome Opens the Door to U.S. Investors -- CFN Media
15/01/2019
SEATTLE, Jan. 15, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Biome Grow Inc. (CSE: BIO) began trading on the OTCQB® on January 2, 2019 with the ticker symbol “BIOIF”. While the company was already listed on the OTC [...]
Forty Seven Inc. to Host Key Opinion Leader Breakfast Symposium on FSI-174, anti-cKIT Antibody, on January 22, 2019
15/01/2019
MENLO PARK, Calif., Jan. 15, 2019 (GLOBE NEWSWIRE) -- Forty Seven Inc. (NASDAQ:FTSV), a clinical-stage, immuno-oncology company focused on developing therapies to activate macrophages in the fight against cancer, today [...]
Apotheca Biosciences (PCFP) Introduces ProMED, Our Newest Flagship Product Line -- Company Begins Rolling Out its Sleep Aid & Opioid Replacement Formulations
15/01/2019
Saint Petersburg, FL, Jan. 15, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Apotheca Biosciences (OTC PINK: PCFP), a developer of cutting-edge medical products, nutraceuticals, drug formulations and cannabis delivery [...]
PetMed Express d/b/a 1-800-PetMeds to Announce Its Third Quarter Financial Results on January 22, 2019
15/01/2019
DELRAY BEACH, Fla., Jan. 15, 2019 (GLOBE NEWSWIRE) -- PetMed Express, Inc. (NASDAQ: PETS) will announce its financial results for the quarter ended December 31, 2018 on Tuesday, January 22, 2019 at 8:00 A.M. Eastern [...]
Galectin Therapeutics’ Largest Institutional Shareholder Converts Existing Series B Preferred Stock Into Common Stock Streamlining Its Capital Structure
15/01/2019
Board Chairman Richard Uihlein extends existing $10 million unsecured line of credit for two additional years NORCROSS, Ga., Jan. 15, 2019 (GLOBE NEWSWIRE) -- Galectin Therapeutics Inc. (NASDAQ: GALT), the leading [...]
AMAG Pharmaceuticals Appoints Christine Moulton Clemson, Ph.D., M.S.C.I. as Vice President of Medical Affairs
15/01/2019
WALTHAM, Mass., Jan. 15, 2019 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced the appointment of Christine Moulton Clemson, Ph.D., M.S.C.I., as vice president, medical affairs, reporting to [...]
Extendicare Announces January 2019 Dividend of C$0.04 per Share
15/01/2019
MARKHAM, Ontario, Jan. 15, 2019 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) announced that it has declared a cash dividend of C$0.04 per common share of the Company (the “Common [...]
TRHC Commends Centers for Medicare and Medicaid Services on Creation of New Opportunities for Dual Medicaid and Medicare Patients
15/01/2019
New recommendations highlight positive changes for PACE participants MOORESTOWN, N.J., Jan. 15, 2019 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc. (TRHC) (NASDAQ: TRHC), a healthcare technology company advancing the [...]
Progressive Care Inc. Announces Best December in Company History
15/01/2019
MIAMI, Jan. 15, 2019 (GLOBE NEWSWIRE) -- Progressive Care Inc. ( OTCQB: RXMD ), a personalized healthcare services and technology company, today announced further growth year-over-year in revenue and number of [...]
Microbot Medical Inc. Announces $3 Million Registered Direct Offering Priced At-the-Market
15/01/2019
HINGHAM, Mass., Jan. 15, 2019 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), a medical device company specializing in the design and development of transformational micro-robotic medical technologies, today [...]
AxoGen Announces RECON® Study Update
15/01/2019
Study Supports Company’s Planned Biologic License Application (BLA) for Avance® Nerve Graft ALACHUA, Fla., Jan. 15, 2019 (GLOBE NEWSWIRE) -- AxoGen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing [...]

Pages